WebMD Prostate Cancer News Library
Get the latest news on Prostate Cancer management, research, treatment advancements and more from WebMD.
www.webmd.comHere are the latest widely reported updates on prostate cancer, based on recent public sources:
New treatment combinations and targeted therapies are showing promise in specific settings, including metastatic and castration-resistant prostate cancer. For example, triplet drug regimens and PARP inhibitors have been highlighted in recent overviews and press summaries as offering survival or progression-free benefits in selected patient groups. These findings come from major cancer organizations and research news outlets that regularly publish updates on emerging regimens and trial results.[1][2]
Advances in diagnostic and prognostic testing continue to shape personalized care. Tests like PHI, 4Kscore, IsoPSA, Sentinel PCa Test, and ConfirmMDx are being discussed as tools to refine risk assessment and biopsy decision-making, though their clinical utility varies by context and guidelines continue to evolve.[2]
Research initiatives and collaboration focus areas include bone metastasis, where charities and research groups are pooling funds to study mechanisms of spread and to develop interventions that could slow or prevent metastatic involvement in bone.[3]
Public awareness and media coverage remain active, with ongoing reporting on new clinical findings, treatment options, and patient stories across major outlets and health portals. For example, organizations like CBS News, WebMD, and ScienceDaily regularly publish updated summaries of research and treatment advances.[4][5][8]
Pan-cancer and cancer-specific research efforts continue to explore immunotherapies, novel vaccines, and next-generation imaging/immuno-oncology approaches, though many of these are in early-phase trials or specialized centers.[6][2]
If you’d like, I can tailor this to a specific aspect (e.g., treatment breakthroughs, diagnostic tests, or patient resources) or provide direct quotes and links to the most current articles from trusted sources. I can also pull a concise, up-to-date digest for Marseille or the Provence-Alpes-Côle d’Azur region if you’re planning local care or referrals.
Would you like a country-wide update with the most recent high-impact studies, or a regional digest focused on France? I can also format this as a quick-read bullet list or a short briefing memo.
Citations:
Get the latest news on Prostate Cancer management, research, treatment advancements and more from WebMD.
www.webmd.comGet the latest Prostate Cancer news, all in one place. Comprehensive Prostate Cancer news aggregated from over 14,000 sources from around the world.
www.newsnow.comLearn the symptoms of prostate cancer. Read current medical research on new treatment options, vaccines, surgery and prevention.
www.sciencedaily.comThe bombshell announcement about former President Joe Biden's prostate cancer came amid longstanding concerns about his health. CBS News New York's Jessica Moore reports. Support is pouring in from across part lines for the former president who revealed over the weekend he's battling prostate cancer. Former President Joe Biden has been diagnosed with an "aggressive form" of prostate cancer that has spread to his bones, his office said in a statement on Sunday. … Buckingham Palace says doctors...
www.cbsnews.comResearch into the causes, prevention, detection, and treatment of prostate cancer is ongoing in many medical centers throughout the world. Find out what's new here.
www.cancer.orgPCR in the news: catch up on all of our latest press coverage and campaigns. From online and offline articles to video clips of our interviews
www.prostate-cancer-research.org.ukMetastatic carcinoma of the prostate is fatal, but a 3-drug combination treatment can prolong life substantially, according to new clinical trial results outlined by The ASCO Post. SEE ALL Grace Anal cancer patient March 22, 2022 … This Business Wire press release announces results from a clinical trial indicating that adding the drug olaparib (brand name Lynparza) to treatment for castrate-resistant prostate cancer enhanced disease-free progression, regardless of biomarker status. March 7, 2019
cancercommons.orgGet the latest news from MD Anderson Cancer Center. The MD Anderson Newsroom provides reporters and the general public with information about the latest studies and findings from our cancer researchers.
www.mdanderson.org